Mechanism sequestering

Additionally, organotin mercaptides can act as antioxidants, as they can sequester free-radical degradation mechanisms (48). The one drawback of mercaptide-based tin stabilizers is the discoloration of the sulfur after exposure to uv-radiation. Special precautions or formulations need to be developed for outdoor apphcations. 

We showed that these mesoporous silica materials, with variable pore sizes and susceptible surface areas for functionalization, can be utilized as good separation devices and immobilization for biomolecules, where the ones are sequestered and released depending on their size and charge, within the channels. Mesoporous silica with large-pore-size stmctures, are best suited for this purpose, since more molecules can be immobilized and the large porosity of the materials provide better access for the substrates to the immobilized molecules. The mechanism of bimolecular adsorption in the mesopore channels was suggested to be ionic interaction. On the first stage on the way of creation of chemical sensors on the basis of functionalized mesoporous silica materials for selective determination of herbicide in an environment was conducted research of sorption activity number of such materials in relation to 2,4-D. 

It has been seen that iron has an adverse effect because it forms a second phase (insoluble) material in the alloy which acts as an effective local cathode. Sequestering is the technique of adding an alloying addition that will cause an alternative intermetallic compound with iron to form. This compound might form a dross to be removed mechanically. Alternatively the new intermetallic compound could be a less effective cathode in which case removal would not be necessary. 

EDTA, leading to a postulate that more than one equivalent of Ca2+ can be captured by X (e.g. one Ca2+ sequestered by the three amines and the three carboxylates and another Ca2 + by the remaining half the donor groups), as the Dreiding model suggests. The fact that there was no interaction at neutral pH of X with phosphate or oxalate anions was separately confirmed. Thus, the dissolution of Ca3(P04)2 and Ca(C204) is entirely due to the cation complexation mechanism. 

Ferritin, an iron-binding protein, prevents ionized iron (Fe ) from reaching toxic levels within cells. Elemental iron stimulates ferritin synthesis by causing the release of a cytoplasmic protein that binds to a specific region in the 5 nontranslated region of ferritin mRNA. Disruption of this protein-mRNA interaction activates ferritin mRNA and results in its translation. This mechanism provides for rapid control of the synthesis of a protein that sequesters Fe +, a potentially toxic molecule. 

Many early studies of transmitter release depended on measuring its concentration in the effluent of a stimulated, perfused nerve/end-organ preparation. This technique is still widely used to study drug-induced changes in noradrenaline release from sympathetic neurons and the adrenal medulla. However, it is important to realise that the concentration of transmitter will represent only that proportion of transmitter which escapes into the perfusate ( overflow ) (Fig. 4.2). Monoamines, for instance, are rapidly sequestered by uptake into neuronal and non-neuronal tissue whereas other transmitters, such as acetylcholine, are metabolised extensively within the synapse. Because of these local clearance mechanisms, the amount of transmitter which overflows into the perfusate will depend not only on the frequency of nerve stimulation (i.e. release rate) but also on the dimensions of the synaptic cleft and the density of innervation. 

The partitioning of the activated inhibitor between direct covalent inactivation of the enzyme and release into solution is an important issue for mechanism-based inactivators. The partition ratio is of value as a quantitative measure of inactivation efficiency, as described above. This value is also important in assessing the suitability of a compound as a drug for clinical use. If the partition ratio is high, this means that a significant proportion of the activated inhibitor molecules is not sequestered as a covalent adduct with the target enzyme but instead is released into solution. Once released, the compound can diffuse away to covalently modify other proteins within the cell, tissue, or systemic circulation. This could then lead to the same types of potential clinical liabilities that were discussed earlier in this chapter in the context of affinity labels, and would therefore erode the potential therapeutic index for such a compound. 

---